icon-    folder.gif   Conference Reports for NATAP  
  (APASL) 25th Conference of the Asian Pacific
Association for the Study of the Liver
Feb 20-24 2016, Tokyo, Japan

Back grey_arrow_rt.gif
Sofosbuvir, Ledipasvir in IBD treated patients with advanced biologics including Ribavirineradicating Chronic Hepatitis C: SOLATAIRE CTrial. A multi-center clinical prospectivepilot study
  Reported by Jules Levin
APASL 2016 Tokyo, Feb 2-24
P. Patrick Basu, MD, MRCP, AGAF1,2, Niraj James Shah, MD3, Nimy John, MD2, S Farhat MD2, Leena Kavali, MD2, E Shehi, MD2, MM Aloysius MD, PhD4, R S Brown Jr, MD, MPH5 1 College of Physicians and Surgeons, Columbia University, New York, NY; 2 King's County Hospital Medical Center, NY;3 Liver Transplant Center, University of North Carolina School of Medicine, Carolinas Medical Center, Charlotte, NC, 4James J. Peters VA Medical Center, Icahn School of Medicine at Mount Sinai, NY 5Weill Cornell Medical College, New York, NY